Rat amylin: cloning and tissue-specific expression in pancreatic islets

Area of Science:

• Molecular biology
• Endocrinology
• Diabetes research

Background:

• Amyloid deposits in pancreatic islets are characteristic of non-insulin-dependent diabetes mellitus.
• Amylin, a 37-amino acid peptide, is the primary component of these deposits and shares similarities with calcitonin gene-related peptide.
• The precise function and origin of amylin in diabetes remain under investigation.

Purpose of the Study:

• To isolate and characterize the rat amylin precursor.
• To investigate the expression patterns of amylin mRNA.
• To explore the potential role of amylin in pancreatic islet function and diabetes.

Main Methods:

• Isolation of complementary DNA (cDNA) clones for the rat amylin precursor from an islet cDNA library.
• Analysis of messenger RNA (mRNA) size and translation products.
• RNA hybridization studies to determine tissue-specific expression of amylin mRNA.
• Investigation of the effect of dietary changes on amylin mRNA levels.

Main Results:

• A 0.9-kilobase mRNA encoding a 93-amino acid precursor for amylin was identified.
• The amylin peptide is flanked by dibasic residues, indicating proteolytic processing similar to calcitonin gene-related peptide.
• Amylin mRNA is highly abundant in pancreatic islets but absent in other examined tissues, including the brain.
• Fasting and refeeding regimens showed minimal impact on amylin mRNA expression.

Conclusions:

• The rat amylin precursor has been molecularly characterized.
• The tissue-specific expression of amylin mRNA in pancreatic islets suggests a specialized role in islet cell function.
• Further research into amylin's signaling pathways may elucidate its involvement in diabetes mellitus.